Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SAR441566 in adults with moderate to severe ulcerative colitis
CTR20252208Phase 2Active
- Sponsor
- Sanofi
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of balinatunfib in autoimmune colitis, sponsored by Sanofi. Started Aug 2025; status: active.
02
Drugs
balinatunfib
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20252208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252208.